TSKU and neuroblastoma: In order to evaluate the clinical relevance of miR-2110-mediated down-regulation of TSKU in neuroblastoma patients, we examined tumor miR-2110 and TSKU mRNA levels in neuroblastoma patients as well as their correlation with patient survival based on the published SEQC neuroblastoma patient dataset [19, 24].